Avant Technologies Inc. (AVAI)
OTCMKTS · Delayed Price · Currency is USD
0.7300
+0.0300 (4.29%)
Jan 21, 2026, 1:04 PM EST
Avant Technologies Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
96.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 276.32K | -644.98K | -70.01% |
| Mar 31, 2022 | 921.31K | -292.80K | -24.12% |
| Mar 31, 2021 | 1.21M | 496.66K | 69.23% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EACO Corporation | 444.96M |
| Netlist | 147.19M |
| Rand Worldwide | 86.70M |
| IPE Universal | 17.33M |
| Fast Finance Pay | 10.35M |
| Spectral Capital | 3.14M |
| Jingbo Technology | 1.85M |
| Livento Group | 1.17M |
Avant Technologies News
- 5 weeks ago - Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment - PRNewsWire
- 6 weeks ago - Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival - PRNewsWire
- 6 weeks ago - Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival - Business Wire
- 6 weeks ago - THE CRITICAL LIST: 5 Stocks Anchoring the New Economy - GlobeNewsWire
- 2 months ago - Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies - Business Wire
- 2 months ago - Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment - Business Wire
- 3 months ago - Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho - PRNewsWire
- 4 months ago - Avant Technologies, Inc. Bolsters Strategic Vision with Targeted Biotech Partnerships for Innovative Cell-Based Therapies - PRNewsWire